REMEDENT, INC.: 10-Q filed 2016-02-16

Name: REMEDENT, INC.: 10-Q filed 2016-02-16
Creator: REMEDENT, INC.

What REMEDENT, INC. reported in its quarterly report filed 2016-02-16 (fiscal Q3 2016): 34 published measures, 102 facts as tagged in accession 0001144204-16-082481.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-02-16
Fiscal period: fiscal Q3 2016
Accession: 0001144204-16-082481 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REMEDENT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-12-31	5,741,230	USD
At 2015-03-31	5,544,796	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	2,302,718	USD
At 2015-03-31	2,032,314	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-12-31	166,948	USD
At 2015-03-31	399,149	USD
At 2014-12-31	97,141	USD
At 2014-03-31	775,286	USD

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-12-31	-20,699,956	USD
At 2015-03-31	-20,974,904	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	19,995,969	shares	92
2015-04-01 to 2015-12-31	19,995,969	shares	275
2014-10-01 to 2014-12-31	19,995,969	shares	92
2014-04-01 to 2014-12-31	19,995,969	shares	275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	19,995,969	shares	92
2015-04-01 to 2015-12-31	19,995,969	shares	275
2014-10-01 to 2014-12-31	19,995,969	shares	92
2014-04-01 to 2014-12-31	19,995,969	shares	275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	0	USD/shares	92
2015-04-01 to 2015-12-31	0.01	USD/shares	275
2014-10-01 to 2014-12-31	0	USD/shares	92
2014-04-01 to 2014-12-31	0.01	USD/shares	275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	0	USD/shares	92
2015-04-01 to 2015-12-31	0.01	USD/shares	275
2014-10-01 to 2014-12-31	0	USD/shares	92
2014-04-01 to 2014-12-31	0.01	USD/shares	275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	1,321	USD	92
2015-04-01 to 2015-12-31	105,013	USD	275
2014-10-01 to 2014-12-31	578	USD	92
2014-04-01 to 2014-12-31	578	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-12-31	428,788	USD
At 2015-03-31	435,268	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	-24,153	USD	92
2015-04-01 to 2015-12-31	230,512	USD	275
2014-10-01 to 2014-12-31	58,661	USD	92
2014-04-01 to 2014-12-31	64,326	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-12-31	2,901,881	USD
At 2015-03-31	2,906,788	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	15,453	USD	92
2015-04-01 to 2015-12-31	47,918	USD	275
2014-10-01 to 2014-12-31	17,544	USD	92
2014-04-01 to 2014-12-31	53,070	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-12-31	3,343,726	USD
At 2015-03-31	3,441,735	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-12-31	756,671	USD
At 2015-03-31	846,773	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-12-31	1,009,297	USD
At 2015-03-31	847,144	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	491,939	USD	92
2015-04-01 to 2015-12-31	1,290,713	USD	275
2014-10-01 to 2014-12-31	475,164	USD	92
2014-04-01 to 2014-12-31	1,683,202	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-12-31	401,860	USD
At 2015-03-31	414,034	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	467,786	USD	92
2015-04-01 to 2015-12-31	1,521,225	USD	275
2014-10-01 to 2014-12-31	533,825	USD	92
2014-04-01 to 2014-12-31	1,747,528	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	3,523	USD	92
2015-04-01 to 2015-12-31	8,753	USD	275
2014-10-01 to 2014-12-31	21,952	USD	92
2014-04-01 to 2014-12-31	61,121	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-12-31	19,995,969	shares
At 2015-03-31	19,995,969	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	2,397,504	USD
At 2015-03-31	2,103,061	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-12-31	2,512,768	USD
At 2015-03-31	2,414,252	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-12-31	2,083,980	USD
At 2015-03-31	1,978,984	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-12-31	287,419	USD
At 2015-03-31	334,748	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	26,596	USD	92
2015-04-01 to 2015-12-31	403,999	USD	275
2014-10-01 to 2014-12-31	11,326	USD	92
2014-04-01 to 2014-12-31	166,408	USD	275

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	25,275	USD	92
2015-04-01 to 2015-12-31	298,986	USD	275
2014-10-01 to 2014-12-31	10,748	USD	92
2014-04-01 to 2014-12-31	165,830	USD	275

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	30,198	USD	92
2015-04-01 to 2015-12-31	270,404	USD	275
2014-10-01 to 2014-12-31	-117,772	USD	92
2014-04-01 to 2014-12-31	13,983	USD	275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	23,661	USD	92
2015-04-01 to 2015-12-31	274,948	USD	275
2014-10-01 to 2014-12-31	5,806	USD	92
2014-04-01 to 2014-12-31	148,642	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	288,021	USD	92
2015-04-01 to 2015-12-31	819,845	USD	275
2014-10-01 to 2014-12-31	235,618	USD	92
2014-04-01 to 2014-12-31	853,278	USD	275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-10-01 to 2015-12-31	50,749	USD	92
2015-04-01 to 2015-12-31	173,487	USD	275
2014-10-01 to 2014-12-31	-47,335	USD	92
2014-04-01 to 2014-12-31	102,082	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-04-01 to 2015-12-31	162,153	USD	275
2014-04-01 to 2014-12-31	31,630	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-04-01 to 2015-12-31	-12,174	USD	275
2014-04-01 to 2014-12-31	-95,938	USD	275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-04-01 to 2015-12-31	-81,185	USD	275
2014-04-01 to 2014-12-31	188,635	USD	275

Inspect the source

Entity: REMEDENT, INC. / CIK 0001078037
Captured: 2026-09-22 19:39 UTC
SEC response SHA-256: 45fceec6324be1015fe5b91364230644b1829b27482c22b4c8e0a8b6c3dc5393

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001078037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))